Primary Location
Foundation for Applied Research in Gastrointestinal Oncology (FARGO)Dr. Paul H. Sugarbaker has been credited with developing the cytoreductive surgery and heated chemotherapy combination surgical oncologists at most mesothelioma specialty centers use today. Many refer to the effective mesothelioma treatment as the Sugarbaker Procedure, which is also the signature treatment for other abdominal cancers. The first step involves cytoreductive surgery that removes the abdominal lining and visible tumor cells. The surgeon then circulates a heated chemotherapy solution throughout the abdominal cavity to kill remaining tumor cells, drains the fluid and closes the surgical incisions. The procedure can take up to 10 hours and has extended patient lives by years.
For more than 30 years, Sugarbaker treated patients at the MedStar Washington Hospital Center in Washington, D.C. He served as chief of the Peritoneal Surface Malignancy Program and director of the Center for Gastrointestinal Malignancies.
Sugarbaker focuses almost exclusively on gynecologic malignancy, gastrointestinal cancer and peritoneal mesothelioma. His laboratory work centers around reducing the peritoneal surface distribution of cancer. His FARGO research group provides the public with information about clinical and scientific research in gastrointestinal cancer.
Specialties of Dr. Paul Sugarbaker
The Sugarbaker name is synonymous with advancing the treatment of mesothelioma cancer. Sugarbaker’s brother, David Sugarbaker, died in 2018, but not before becoming the first thoracic surgeon to embrace the challenge of treating pleural mesothelioma, giving hope to those who once had none.
Paul Sugarbaker did much the same for peritoneal mesothelioma. He performed the first Sugarbaker Procedure more than two decades ago, offering his expertise to young surgeons worldwide to build on what he started. He has visited all five continents to teach others through the years.
Sugarbaker travels to Europe annually to teach a course in peritoneal surgical oncology. He has written books and made videos on the topic. He lectures extensively and is on the editorial board of 11 medical journals.
“I think part of your obligation as an innovator is to pass on what you learned and what you accomplished so that others can expand on it,” he said. “We both saw ourselves trying to bring new and beneficial things to those with this rare disease. You help everyone that way.”
Connect with top-rated doctors specializing in mesothelioma treatment, who will personalize treatment options based on your diagnosis.
Find Your DoctorMesothelioma specialists across the world perform techniques pioneered by Sugarbaker. His methods and training have improved the lives of countless mesothelioma patients.
Dr. Jesus Esquivel, Frederick Memorial Hospital
“We are very grateful for his impact in the country where I am from. He is responsible for bringing the Sugarbaker Procedure to Mexico through his pioneering efforts. Because of him, we opened the first peritoneal and HIPEC workshop there.”
Dr. Marcello Deraco, National Cancer Institute of Milan, Italy
“No other treatment has ever had such an impact on the quality of life for patients with mesothelioma than the surgical concept [Paul] introduced.”
Dr. Brendan Moran, Peritoneal Malignancy Institute, Basingstoke, U.K.
“He is a tireless innovator and one of the legends of our time. I consider Paul Sugarbaker to be the global leader in surgical oncology.”
Dr. Paul Sugarbaker is a leading expert on peritoneal mesothelioma. He is recognized globally for his innovative surgical procedures that significantly extend patient survival times.
The Sugarbaker Procedure is a combination therapy that involves cytoreductive surgery to remove tumor masses, followed by circulating heated chemotherapy in the abdomen to kill remaining tumor cells. Dr. Paul Sugarbaker is credited with developing this breakthrough therapy, which has extended survival for peritoneal mesothelioma patients by 10 years or more.
HIPEC is an effective treatment for peritoneal mesothelioma patients. The average survival for peritoneal mesothelioma patients was approximately six months before the availability of HIPEC treatment. With the introduction of HIPEC therapy, 50% of patients now live longer than five years.
Choosing the right mesothelioma doctor involves researching their years of experience treating mesothelioma. You will also want to verify that your insurance plan covers your doctor.
Dr. Paul Sugarbaker currently practices in a limited capacity at Sugarbaker Oncology Associates in Washington, D.C. His primary focus is the research group he founded in 1993, the Foundation for Applied Research in Gastrointestinal Oncology.
FARGO continues to promote research, education and patient care in gastrointestinal oncology. The goal is to provide international support for clinicians and researchers to improve treatment options and outcomes for gastrointestinal cancer patients.
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
Stay up-to-date on treatment, research, clinical trials, doctors and survivors
The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our privacy policy and terms of service for more information about our website.
This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome.
The Mesothelioma Center’s claim as the most trusted resource is based on our more than 150 5-star Google and BBB reviews. Our organization also helps more than half of all mesothelioma patients annually diagnosed.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
